Antibe Therapeutics Inc
TSX:ATE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Antibe Therapeutics Inc
TSX:ATE
|
CA |
|
T
|
TQM Alpha PCL
SET:TQM
|
TH |
|
Rocky Mountain Chocolate Factory Inc (Delaware)
NASDAQ:RMCF
|
US |
Shareholder Yield
Current shareholder yield for ATE is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
ATE Price
Antibe Therapeutics Inc
| Average Annual Return | -55.99% |
| Standard Deviation of Annual Returns | 43.3% |
| Max Drawdown | -97% |
| Market Capitalization | 4.7m CAD |
| Shares Outstanding | 16 063 094 |
| Percentage of Shares Shorted | 0.11% |
ATE Return Decomposition
Main factors of price return
Stock Splits
ATE's latest stock split occurred on Oct 11, 2023
The company executed a 4-for-1 stock split, meaning that for every share held, investors received 4 new shares.
Before the split, ATE traded at 0.485 per share. Afterward, the share price was about 0.475.
The adjusted shares began trading on Oct 11, 2023. This was ATE's 3rd stock split, following the previous one in Dec 1, 2020.
